Graphic illustration of where we were with COVID-19 response as of 31 July 2020.
1- EPIDEMIOLOGIC UPDATE
2- EQUIPMENT SUPPORT TO MEMBER STATES
3- NUMBER OF HEALTHCARE WORKERS TRAINED
4- STRATEGIC ACTION UPDATE
5- PERSONNEL DEPLOYMENTS BY COUNTRY
6- AFRICA CDC TARGETS
7- COVID-19 tests conducted by Member States as of 31 July 2020
This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.
We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.
Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH
Publication date: October 2024
| File | Action |
|---|---|
| African Vaccine Manufacturing Mapping | Supply and Demand Landscape | Download |
